NOX 4.17% 6.9¢ noxopharm limited

Ann: Major Survival Benefit in Prostate Cancer Patients Announced, page-36

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Agree Philley re presentation potential.
    As a combined study add-on, I’m holding mid to long term to see if a licensing/Take-over transpires.
    Best If luck to all that hold.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.